prism 8 v.8.2.1 software (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
prism 8 v.8.2.1 software
Prism 8 V.8.2.1 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+8+v%2E8%2E2%2E1+software/prism+software/pm36208838-104-8-12
Average 90 stars, based on 1 article reviews
Prism 8 V.8.2.1 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+8+v%2E8%2E2%2E1+software/prism+software/pm36208838-104-8-12
Average 90 stars, based on 1 article reviews
prism 8 v.8.2.1 software - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model. Article Snippet: The curve of remaining radioactivity in the eye (%) versus time and curves of the SUV in blood, heart, liver, spleen and cervical lymph nodes in each rat versus time after intravitreal injection of 89Zr-adalimumab were generated using GraphPad Article Title: Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop Article Snippet: K 1:1 and K 1:2 values were calculated by Article Title: Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop Article Snippet: The analysis was carried out using Article Title: PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model. Article Snippet: Compartmental data analyses were carried out using GraphPad Article Title: Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop Article Snippet: The percentage of unaltered drug versus time was fitted to a first order kinetics using Article Title: Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire. Article Snippet: The Injection:Article Title: PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model. Article Snippet: The curve of remaining radioactivity in the eye (%) versus time and curves of the SUV in blood, heart, liver, spleen and cervical lymph nodes in each rat versus time after intravitreal injection of 89Zr-adalimumab were generated using GraphPad Article Title: Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop Article Snippet: K 1:1 and K 1:2 values were calculated by Article Title: Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop Article Snippet: The analysis was carried out using Article Title: PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model. Article Snippet: Compartmental data analyses were carried out using GraphPad Article Title: Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop Article Snippet: The percentage of unaltered drug versus time was fitted to a first order kinetics using Article Title: Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire. Article Snippet: The Radioactivity:Article Title: PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model. Article Snippet: The curve of remaining radioactivity in the eye (%) versus time and curves of the SUV in blood, heart, liver, spleen and cervical lymph nodes in each rat versus time after intravitreal injection of 89Zr-adalimumab were generated using GraphPad Article Title: Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop Article Snippet: K 1:1 and K 1:2 values were calculated by Article Title: Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop Article Snippet: The analysis was carried out using Article Title: PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model. Article Snippet: Compartmental data analyses were carried out using GraphPad Article Title: Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop Article Snippet: The percentage of unaltered drug versus time was fitted to a first order kinetics using Article Title: Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire. Article Snippet: The Generated:Article Title: PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model. Article Snippet: The curve of remaining radioactivity in the eye (%) versus time and curves of the SUV in blood, heart, liver, spleen and cervical lymph nodes in each rat versus time after intravitreal injection of 89Zr-adalimumab were generated using GraphPad Article Title: Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop Article Snippet: K 1:1 and K 1:2 values were calculated by Article Title: Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop Article Snippet: The analysis was carried out using Article Title: PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model. Article Snippet: Compartmental data analyses were carried out using GraphPad Article Title: Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop Article Snippet: The percentage of unaltered drug versus time was fitted to a first order kinetics using Article Title: Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire. Article Snippet: The |